Latest News of MXC
MaxCyte Inc (MXCT) Q3 2024 Earnings Call Highlights: Strong Core Revenue Growth Amidst Market ...
By Yahoo! Finance |
6 days ago
Maher Masoud discussed inventory write-down due to product redesign and new engineering head hired for efficient development. Vertex focuses on high-impact workflows and revenue to avoid future losses...
Insider Buying: President and CEO Maher Masoud Acquires 100,000 Shares of MaxCyte Inc (MXCT)
By Yahoo! Finance |
5 months ago
Maher Masoud, CEO of MaxCyte Inc, bought 100,000 shares at $4.89, investing $489,000. With a total of 200,000 shares, he has shown confidence in the company's cell engineering technologies....